Loading organizations...

§ Venture Capital · Glendale, CA, USA
Venture capital firm investing in multi-stage companies with $2MM-$10MM checks, focused on biotech, deep tech, and medtech.
Black Diamond Ventures is a venture capital firm based in Glendale, California, with an additional office in Los Gatos, that invests in multi-stage companies across the biotechnology, deep tech, and medical technology sectors. The firm primarily targets Series B, later-stage, and growth capital funding rounds for businesses developing artificial intelligence, big data, machine learning, materials science, and semiconductor technologies. The organization raises capital from individual investors and deploys it through vehicles such as the BDV Opportunity Fund, writing initial and follow-on investment checks ranging from $2 million to $10 million per deal. Black Diamond Ventures frequently co-invests alongside first-tier institutional partners and has backed a portfolio of companies that includes Prellis Biologics, Ares Materials, DexCom, and DivX Networks. The investment firm was founded by Christopher B. Lucas to provide strategic support to private technology enterprises.
Key people at Black Diamond Ventures.
Black Diamond Ventures (BDV) is a venture capital firm that invests in cutting-edge technology sectors including medtech, biotech, semiconductors, AI, big data, and robotics. Founded in 1998 and headquartered in Glendale, California, BDV focuses on multi-stage investments in visionary founders developing market-transforming technologies primarily within deep tech and biotech verticals. The firm targets companies with proprietary technology solutions addressing large, quantifiable markets, typically operating in B2B or B2B2C business models. BDV provides capital, resources, and access to a strong network of investors and founders, thereby playing a significant role in nurturing innovation and growth in the startup ecosystem within these advanced technology sectors[1][2][6].
Black Diamond Ventures was founded in 1998 by Christopher B. Lucas and is based in Glendale, California, with additional offices in Silicon Valley. Over time, BDV has evolved to concentrate its investment thesis on deep tech and biotech sectors, including AI, machine learning, materials science, semiconductors, and medtech. The firm has built a reputation for supporting companies from early revenue stages through growth capital rounds, emphasizing visionary founders and proprietary technologies. This evolution reflects BDV’s commitment to backing transformative technologies that have the potential to disrupt established markets and create new ones[1][2][5].
Black Diamond Ventures rides the wave of accelerating innovation in deep tech and biotech, sectors driven by advances in AI, machine learning, materials science, and medical technology. The timing is critical as these fields are experiencing rapid growth due to increasing computational power, data availability, and urgent healthcare needs. BDV’s focus on proprietary technologies and large markets aligns with broader market forces favoring scalable, high-impact solutions in healthcare, semiconductors, and AI-driven analytics. By funding visionary founders and providing them with strategic resources, BDV influences the broader ecosystem by accelerating the commercialization of breakthrough technologies and fostering a vibrant innovation environment in California and beyond[1][2][6].
Looking ahead, Black Diamond Ventures is well-positioned to capitalize on emerging trends such as AI integration in biotech, advanced semiconductor materials, and robotics automation. The firm’s continued emphasis on visionary founders and proprietary technology will likely drive its influence deeper into these sectors. As market demands for precision medicine, AI-powered analytics, and next-generation hardware grow, BDV’s portfolio companies could become key players shaping the future of technology and healthcare. The firm’s entrepreneurial approach and strong network will remain critical assets in navigating the evolving landscape, potentially expanding its reach and impact globally[2][6].
Key people at Black Diamond Ventures.
Black Diamond Ventures has 11 tracked investments across 7 companies. The latest tracked deal is $6.6M Seed in Lyric Bio in December 2025.